MSET Share Price Performance
Recent MSET News & Updates
No updates
Mindset Pharma Inc. Key Details
Last Reported Earnings
Mar 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.06
- Gross Margin
- 100.00%
- Net Profit Margin
- -78.82%
- Debt/Equity Ratio
- 0%
Mindset Pharma Inc. Competitors
About MSET
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
Canadian Market Performance
- 7 Days: 0.7%
- 3 Months: 10.9%
- 1 Year: 17.6%
- Year to Date: 10.6%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector gained 4.2% in that time. As for the longer term, the market has risen 18% in the past 12 months. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading